Short communicationHigh concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity
References (11)
- et al.
Naloxone in experimental spinal cord ischemia: dose-response studies
European J. Pharmacol.
(1984) - et al.
Ketamine and phencylidine cause a voltage dependent block of responses of L-aspartic acid
Neurosci. Lett.
(1985) - et al.
Brain and serum levels of naloxone following peripheral administration
Life Sci.
(1983) - et al.
Variation of cerebral cortex fluid spaces in vivo as a function of species brain size
Am. J. Physiol.
(1965) - et al.
Glutamate neurotoxicity in cortical cell culture
J. Neurosci.
(1987)
There are more references available in the full text version of this article.
Cited by (28)
Naloxone lowers cerebrospinal fluid levels of excitatory amino acids after thoracoabdominal aortic surgery
2004, Journal of Vascular SurgeryCitation Excerpt :The mechanism by which naloxone attenuates CSF levels of EAAs remains unclear because naloxone has been believed to be a nonselective opioid receptor antagonist. Kim et al9 have demonstrated that high concentrations of naloxone could partially antagonize NMDA receptor-mediated neurotoxicity in an animal model. However, it has been unknown whether a very low dose of naloxone, which has been used during thoracoabdominal aortic replacement,1 can ameliorate NMDA-mediated excitotoxicity or not.
Pathophysiology of the Blood-Spinal Cord Barrier in Traumatic Injury
2004, Blood-Spinal Cord and Brain Barriers in Health and DiseaseThe Heat Shock Proteins and Hemeoxygenase Response in Central Nervous System Injuries
2004, Blood-Spinal Cord and Brain Barriers in Health and DiseaseEffects of GABAergic Drugs on the Recovery of Reflex Potentials after Spinal Cord Ischemia in Cats
1995, The Japanese Journal of PharmacologyThe opioid receptor antagonist naloxone influences the pathophysiology of spinal cord injury
1995, Progress in Brain Research
Copyright © 1987 Published by Elsevier B.V.